Revolutionizing Healthcare with Precision Surgery: Centerline Biomedical Secures $33M in Series B Funding

Centerline Biomedical, Inc., a leader in surgical navigation and precision healthcare, has successfully raised a significant $33 million in funding to further advance its pioneering technologies. Established in 2014 as a spinoff from the renowned Cleveland Clinic, Centerline is on a mission to transform healthcare delivery by equipping physicians with cutting-edge imaging solutions that enhance surgical outcomes while minimizing costs and radiation exposure for both patients and caregivers. The funding will be primarily allocated towards the commercialization and continuous improvement of the Intra-Operative Positioning System (IOPS™), a groundbreaking mobile 3D vascular navigation platform designed to revolutionize minimally invasive endovascular procedures. Unlike traditional x-ray fluoroscopy, which has notable limitations such as poor soft tissue visualization and harmful ionizing radiation exposure, the IOPS™ creates real-time, manipulable 3D models from existing imaging data, allowing for unparalleled precision and control during surgical interventions. As millions of vascular procedures are performed annually, the IOPS™ stands to not only decrease the risk of complications such as endoleaks but also streamline complex procedures by enabling healthcare providers to make well-informed clinical decisions rapidly. With a multidisciplinary team of experts from various fields, including scientists, clinicians, engineers, and software architects, Centerline Biomedical is not only committed to enhancing the current surgical practices but is also poised to contribute significantly to predictive modeling, clinical training, and global healthcare analytics. Watch the innovative IOPS™ technology in action at [this link](https://youtu.be/U8RL3_UNP8Q).